1. Home
  2. VPG vs ESPR Comparison

VPG vs ESPR Comparison

Compare VPG & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VPG

Vishay Precision Group Inc.

N/A

Current Price

$43.44

Market Cap

715.7M

Sector

Technology

ML Signal

N/A

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

N/A

Current Price

$3.04

Market Cap

793.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VPG
ESPR
Founded
2009
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
715.7M
793.7M
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
VPG
ESPR
Price
$43.44
$3.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$53.50
$8.25
AVG Volume (30 Days)
283.4K
3.4M
Earning Date
01-01-0001
04-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
86.21
EPS
0.40
N/A
Revenue
$307,202,000.00
$332,314,000.00
Revenue This Year
$7.21
$27.35
Revenue Next Year
$6.92
N/A
P/E Ratio
$108.25
N/A
Revenue Growth
0.22
185.66
52 Week Low
$18.57
$0.73
52 Week High
$56.25
$4.18

Technical Indicators

Market Signals
Indicator
VPG
ESPR
Relative Strength Index (RSI) 41.96 41.62
Support Level $37.61 $2.36
Resistance Level $49.72 $3.02
Average True Range (ATR) 2.78 0.17
MACD -0.68 -0.06
Stochastic Oscillator 25.95 34.93

Price Performance

Historical Comparison
VPG
ESPR

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: